AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Emtricitabine/Tenofovir Alafenamide in Ghana
6 products registered with FDA Ghana — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOBATAF-EM TABLETS (Each film-coated tablet contains Emtricitabine/Tenofovir Alafenamide /200mg/25mg) | UNKNOWN-c7ec0baf | — | active | 1 Apr 2031 |
| DOBATAF-EM TABLETS (Each film-coated tablet contains Emtricitabine/Tenofovir Alafenamide /200mg/25mg) | UNKNOWN-3c403578 | — | active | 1 Apr 2031 |
| DOBATAF-3 TABLETS Each contains Emtricitabine/Tenofovir Alafenamide 200mg/25mg) | UNKNOWN-1a60b78c | — | active | 4 Jan 2031 |
| DOBATAF-3 TABLETS Each contains Emtricitabine/Tenofovir Alafenamide 200mg/25mg) | UNKNOWN-fbc8b59a | — | active | 4 Jan 2031 |
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS | UNKNOWN-7b9b6390 | — | active | 31 Dec 2029 |
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS | UNKNOWN-c776ce80 | — | active | 31 Dec 2029 |
Emtricitabine/Tenofovir Alafenamide — FDA Ghana Registration Details
FDA Ghana (Ghana) has 6 registered products containing Emtricitabine/Tenofovir Alafenamide, of which 6 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Emtricitabine/Tenofovir Alafenamide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.